Yubo International Biotech Limited
YBGJ · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,981 | $8,867 | $5,919 | $4,153 |
| - Cash | $11 | $10 | $10 | $7 |
| + Debt | $139 | $185 | $231 | $479 |
| Enterprise Value | $2,109 | $9,041 | $6,141 | $4,624 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | – | – | 100% | – |
| Gross Profit | -$44 | -$45 | -$45 | -$0 |
| % Margin | – | – | – | 72.2% |
| EBITDA | -$267 | -$205 | -$423 | -$311 |
| % Margin | – | – | – | 1,725,672.2% |
| Net Income | -$277 | -$230 | -$436 | -$290 |
| % Margin | – | – | – | 1,609,188.9% |
| EPS Diluted | -0.002 | -0.002 | -0.004 | -0.002 |
| % Growth | 0% | 47.2% | -50% | – |
| Operating Cash Flow | -$359 | $37 | -$392 | -$933 |
| Capital Expenditures | -$0 | $6 | -$6 | $0 |
| Free Cash Flow | -$359 | $43 | -$398 | -$933 |